Published in Proteomics Weekly, May 30th, 2005
"The properties of U-II receptor (AT receptor) and angiotensin II (ANG II) receptor (AT receptor) in primary HSMM and differentiated skeletal myotubes (HSMMT) were characterized," wrote J.S. Qi and colleagues, Johnson & Johnson Pharmaceutical Research & Development LLC.
"Radiolabeled U-II and ANG TI bound specifically to HSMM with K-d's of 0.31 nM (2311 receptors/cell) and 0.61 nM (18,257 receptors/cell), respectively. The cyclic segment of U-II peptide,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.